Life Sciences

Advanced Therapy Medicinal Products (ATMPs) are changing the face of medicine, but with all the opportunity and rapid change comes a host of challenges. Here’s a look at the state of the ATMP industry and important considerations for manufacturers chasing success.

New uses for oligonucleotides and increasing demand are driving oligo manufacturers to scale up to commercial production.

There is a global shift towards achieving a sustainable future. This provides a valuable opportunity for biopharmaceutical companies to become a driver of positive change.

The cell and gene industry is a competitive, exciting field that is centered on rapidly evolving science. It’s a vibrant world with unlimited possibilities—and with clever interior design, its facilities can reflect that same energy.

Keeping your plasma fractionation process and facility cold requires careful planning and design.

After decades of research, the oligonucleotide industry has reached a tipping point and is experiencing a huge surge of interest and momentum.

When it comes to highly complex plasma fractionation facilities, integrated project delivery is an optimal way to design and build.